Abeona Therapeutics Inc. (LON:0H7R)
4.969
-0.060 (-1.19%)
Feb 12, 2026, 4:51 PM GMT
Abeona Therapeutics Revenue
Revenue (ttm)
$297.58K
Revenue Growth
n/a
P/S Ratio
667.10
Revenue / Employee
$2.19K
Employees
136
Market Cap
198.51M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 3.50M | 2.09M | 147.52% |
| Dec 31, 2022 | 1.41M | -1.59M | -52.87% |
| Dec 31, 2021 | 3.00M | -7.00M | -70.00% |
| Dec 31, 2020 | 10.00M | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | 3.00M | 2.16M | 258.18% |
| Dec 31, 2017 | 837.00K | -52.00K | -5.85% |
| Dec 31, 2016 | 889.00K | -151.00K | -14.52% |
| Dec 31, 2015 | 1.04M | 115.00K | 12.43% |
| Dec 31, 2014 | 925.00K | -1.12M | -54.70% |
| Dec 31, 2013 | 2.04M | -2.36M | -53.63% |
| Dec 31, 2012 | 4.40M | 2.57M | 139.48% |
| Dec 31, 2011 | 1.84M | 1.36M | 282.33% |
| Dec 31, 2010 | 481.00K | 129.00K | 36.65% |
| Dec 31, 2009 | 352.00K | 61.00K | 20.96% |
| Dec 31, 2008 | 291.00K | 234.00K | 410.53% |
| Dec 31, 2007 | 57.00K | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Integrated Diagnostics Holdings | 114.96M |
| Optima Health | 113.75M |
| Animalcare Group | 81.07M |
| Tristel | 46.46M |
Abeona Therapeutics News
- 3 days ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 22 days ago - Insider Sell: Mark Alvino Sells 13,500 Shares of Abeona Therapeutics Inc (ABEO) - GuruFocus
- 6 weeks ago - Abeona Therapeutics (ABEO) Issues Equity Awards to New Staff - GuruFocus
- 6 weeks ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Insider Sell: Vishwas Seshadri Sells 25,000 Shares of Abeona Therapeutics Inc (ABEO) - GuruFocus
- 2 months ago - Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer - GlobeNewsWire
- 2 months ago - Abeona Therapeutics (ABEO) Expands Zevaskyn Treatment Access in Texas - GuruFocus
- 2 months ago - Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas - GlobeNewsWire